An FDA advisory panel splits 8-8 on whether to recommend that Abbott Labs' (ABT) Meridia diet...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

An FDA advisory panel splits 8-8 on whether to recommend that Abbott Labs' (ABT) Meridia diet pill stay on the market after a study linked the pill to more heart attacks, strokes and deaths. Meridia has already been pulled in Europe, and Abbott estimates about $30M in U.S. sales this year. (PR)